Cargando…

Gene methylation as a powerful biomarker for detection and screening of non-small cell lung cancer in blood

DNA methylation has been reported to become a potential powerful tool for cancer detection and diagnosis. However, the possibilities for the application of blood-based gene methylation as a biomarker for non-small cell lung cancer (NSCLC) detection and screening remain unclear. Hence, we performed t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bao-hua, Li, Yan-yu, Han, Jin-zhu, Zhou, Lian-ya, Lv, Ying-qian, Zhang, He-lin, Zhao, Li
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5458240/ https://www.ncbi.nlm.nih.gov/pubmed/28404957 http://dx.doi.org/10.18632/oncotarget.15919

Ejemplares similares

Identification and validation of the methylation biomarkers of non-small cell lung cancer (NSCLC)
por: Guo, Shicheng, et al.
Publicado: (2015)

Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer
por: Gu, Wanjun, et al.
Publicado: (2020)

DNA methylation-based biomarkers for early detection of non-small cell lung cancer: an update
por: Anglim, Paul P, et al.
Publicado: (2008)

Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer
por: Szczyrek, Michał, et al.
Publicado: (2021)

Screening and identification of novel candidate biomarkers of focal cortical dysplasia type II via bioinformatics analysis
por: Wang, Jiang-ya, et al.
Publicado: (2022)

Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer
por: Li, Peilong, et al.
Publicado: (2022)

Midkine is a serum and urinary biomarker for the detection and prognosis of non-small cell lung cancer
por: Xia, Xin, et al.
Publicado: (2016)

Blood-based DNA Methylation Biomarkers for Early Detection of Colorectal Cancer
por: Dong, Lixn, et al.
Publicado: (2018)

Genome-wide methylation profiling reveals differentially methylated genes in blood DNA of small-cell lung cancer patients
por: He, Yanqi, et al.
Publicado: (2022)

Circulating TP73‐AS1 and CRNDE serve as diagnostic and prognostic biomarkers for non‐small cell lung cancer
por: Yuan, Rong‐Xia, et al.
Publicado: (2022)

PRKCDBP Methylation is a Potential and Promising Candidate Biomarker for Non-small Cell Lung Cancer
por: LI, Jing, et al.
Publicado: (2022)

DNA Methylation in Peripheral Blood: A Potential Biomarker for Cancer Molecular Epidemiology
por: Li, Lian, et al.
Publicado: (2012)

A panel of DNA methylation biomarkers for detection and improving diagnostic efficiency of lung cancer
por: Wei, Bing, et al.
Publicado: (2021)

ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer
por: Lv, Meiwen, et al.
Publicado: (2022)

Whole-genome DNA methylation and DNA methylation-based biomarkers in lung squamous cell carcinoma
por: Cai, Qidong, et al.
Publicado: (2023)

MGMT gene promoter methylation in humoral tissue as biomarker for lung cancer diagnosis: An update meta‐analysis
por: Chen, Bizheng, et al.
Publicado: (2021)

DNA methylation biomarkers discovered in silico detect cancer in liquid biopsies from non-small cell lung cancer patients
por: Vrba, Lukas, et al.
Publicado: (2019)

Methylated Septin9 (mSEPT9): A Promising Blood-Based Biomarker for the Detection and Screening of Early-Onset Colorectal Cancer
por: Loomans-Kropp, Holli A., et al.
Publicado: (2022)

Serum-Based DNA Methylation Biomarkers in Colorectal Cancer: Potential for Screening and Early Detection
por: Summers, Thomas, et al.
Publicado: (2013)

Integrating DNA methylation and microRNA biomarkers in sputum for lung cancer detection
por: Su, Yun, et al.
Publicado: (2016)

Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis
por: Ye, Meng, et al.
Publicado: (2016)

Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer
por: Feng, Hongxiang, et al.
Publicado: (2020)

The methylation profiles of PRDM promoters in non–small cell lung cancer
por: Tan, Shuang-xiang, et al.
Publicado: (2018)

Serum and blood based biomarkers for lung cancer screening: a systematic review
por: Chu, Gavin C. W., et al.
Publicado: (2018)

Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma
por: Yu, Xin-Min, et al.
Publicado: (2016)

Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation
por: Liu, Chong, et al.
Publicado: (2021)

Genome-Scale Discovery of DNA-Methylation Biomarkers for Blood-Based Detection of Colorectal Cancer
por: Lange, Christopher P. E., et al.
Publicado: (2012)

A novel screening method of DNA methylation biomarkers helps to improve the detection of colorectal cancer and precancerous lesions
por: Li, Yuan, et al.
Publicado: (2023)

DNA methylation biomarkers in stool for early screening of colorectal cancer
por: Chen, Jie, et al.
Publicado: (2019)

Screening and identifying of biomarkers in early colorectal cancer and adenoma based on genome-wide methylation profiles
por: He, Chungang, et al.
Publicado: (2023)

Epigenetic Biomarkers Screening of Non-Coding RNA and DNA Methylation Based on Peripheral Blood Monocytes in Smokers
por: Huang, Xiaowei, et al.
Publicado: (2022)

Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non‐small cell lung cancer
por: Liu, Wei‐Ran, et al.
Publicado: (2020)

IDH2 is a novel diagnostic and prognostic serum biomarker for non‐small‐cell lung cancer
por: Li, Jiang‐jiang, et al.
Publicado: (2018)

Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening
por: Wu, Yijun, et al.
Publicado: (2023)

Metabolic biomarkers in lung cancer screening and early diagnosis (Review)
por: Xu, Yongjie, et al.
Publicado: (2023)

Promoter methylation of ADAMTS1 and BNC1 as potential biomarkers for early detection of pancreatic cancer in blood
por: Eissa, Maryam A. L., et al.
Publicado: (2019)

Emerging Blood-Based Biomarkers for Predicting Response to Checkpoint Immunotherapy in Non-Small-Cell Lung Cancer
por: Li, Shumin, et al.
Publicado: (2020)

Identification and validation of novel prognostic biomarkers and therapeutic targets for non-small cell lung cancer
por: Lai, Li-Ting, et al.
Publicado: (2023)

Urinary malate dehydrogenase 2 is a new biomarker for early detection of non‐small‐cell lung cancer
por: Ma, Yu‐Chen, et al.
Publicado: (2021)

Plasma small ncRNA pair panels as novel biomarkers for early-stage lung adenocarcinoma screening
por: Dou, Yuhong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_a4u5140vqu882k6dtkkrg9h6a4